APA

Papewalis C., Wuttke M., Schinner S., Willenberg H. S., Baran A. M., Scherbaum W. A. & Schott M. (20091202). Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. : Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Chicago

Papewalis C, Wuttke M, Schinner S, Willenberg H S, Baran A M, Scherbaum W A and Schott M. 20091202. Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. : Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Harvard

Papewalis C., Wuttke M., Schinner S., Willenberg H. S., Baran A. M., Scherbaum W. A. and Schott M. (20091202). Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. : Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

MLA

Papewalis C, Wuttke M, Schinner S, Willenberg H S, Baran A M, Scherbaum W A and Schott M. Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. : Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 20091202.